Palvella Therapeutics COO Kathleen Goin reports sale of 4,302 common shares worth $654,184.41
PVLA•Insider sale and option exercise
- Palvella Therapeutics COO Kathleen Goin exercised stock options on Aug. 19, 2026, acquiring 4,302 common shares at USD 7.14–9.08.
- She sold 4,302 common shares the same day at weighted-average prices around USD 151.39–156.77.
- Her direct common stock ownership fell to zero following the transactions.
